| Watchers | 11,165 |
| 52-Wk Low | $320.01 |
| 52-Wk High | $448.40 |
| Market Cap | $110.94B |
| Volume | 939,753.00 |
| 52-Wk High | $448.40 |
| 52-Wk Low | $320.01 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Vertex Pharmaceuticals, Inc. market cap is $110.94B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vertex Pharmaceuticals, Inc. 52 week high is $448.40 as of May 14, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vertex Pharmaceuticals, Inc. 52 week low is $320.01 as of May 14, 2024.
Vertex Pharmaceuticals, Inc. stock price today is $429.93.
Vertex Pharmaceuticals, Inc. stock price yesterday was $422.78.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Vertex Pharmaceuticals, Inc.’s P/E ratio is 27.89.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Vertex Pharmaceuticals, Inc. P/B ratio is 5.9876.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Vertex Pharmaceuticals, Inc.'s EBITDA is 22.93.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Vertex Pharmaceuticals, Inc. 50-day moving average is $407.86.
Vertex Pharmaceuticals, Inc. has 5,400 employees.